Latest Research in Adenosine and Purinergic Signaling

Top Research Topics in Adenosine and Purinergic Signaling

• Gut microbiota and health — 4 papers
• Adenosine and Purinergic Signaling — 1 papers
• Psychedelics and Drug Studies — 1 papers
• Drug-Induced Hepatotoxicity and Protection — 1 papers
• Inflammatory Bowel Disease — 1 papers
• Chemotherapy-induced organ toxicity mitigation — 1 papers
• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis — 1 papers
• Kidney Stones and Urolithiasis Treatments — 1 papers
• Liver Diseases and Immunity — 1 papers

Highest-Cited Papers

1. P2X4 Receptor Antagonists Exert Anti-Inflammatory Effects via NLRP3 Inflammasome in a Murine Model of Colitis
2. Structure-based design of subtype-selective psychedelic analogs
3. Fused Azine Derivatives Mitigate Long-Term Paracetamol-Induced Liver Fibrosis in Mice: Role of JNK1/ASK1 and Nrf2/HO-1 Signaling Pathways
4. Integrated Multi-Omics Reveals Complementary Luminal and Mucosal Host–Microbiome Interactions Associated with Disease Activity and Phenotype in Paediatric Inflammatory Bowel Disease
5. Insights into the protective role of trigonelline in 5-fluorouracil–induced lung injury: targeting oxidative stress, inflammation, and apoptosis
6. Gut microbiota dynamics and metabolic pathways associated with bleomycin-induced pulmonary fibrosis progression
7. Determinants of enteric hyperoxaluria in the SAMP1/YitFc mouse model of spontaneous ileitis
8. Integrated absolute-quantitative gut microbiota profiling and targeted metabolomics reveal microbial and metabolic alterations in children with juvenile idiopathic arthritis
9. Gut Microbiota and Metabolic Pathway Signatures for Inflammatory Bowel Disease Identified via Subject-Stratified Random Forest Based on the Longitudinal HMP2 Cohort
10. Genome-Resolved Functional Profiling of Osteoporosis-Associated Gut Bacteria Highlights Putative Metabolic and Immunogenic Signatures of the Gut–Bone Axis
11. Oral Colonisation of the Gut May Explain the Cirrhosis Virome Signature
12. Aflatoxin B1, Gut Microbiota Dysbiosis, and the Intestinal Barrier: Implications for the Gut–Liver Axis and Extrahepatic Cancer Risk